Palacios Wealth Management’s AbbVie ABBV Stock Holding History

Palacios Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Sell	6,318 -244	-4%	-$52.5K	0.94%	23
2026 Q1	$1.39M	Sell	6,562 -544	-8%	-$121K	0.87%	22
2025 Q4	$1.62M	Sell	7,106 -739	-9%	-$168K	1.24%	21
2025 Q3	$1.82M	Sell	7,845 -806	-9%	-$164K	1.2%	20
2025 Q2	$1.61M	Sell	8,651 -227	-3%	-$42.2K	1.32%	19
2025 Q1	$1.86M	Sell	8,878 -90	-1%	-$17.5K	1.38%	13
2024 Q4	$1.54M	Buy	+8,968	New	+$1.65M	1.67%	15

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Palacios Wealth Management's ABBV Position: Q2 2026 in Review

Palacios Wealth Management reduced its AbbVie (ABBV) stake by 3.7% in Q2 2026, selling an estimated $52.5K and leaving 6,318 shares worth $1.59M. The position accounts for 0.94% of the portfolio, ranked #23.

Palacios Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.86M in Q1 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Palacios Wealth Management held 6,318 shares of AbbVie worth $1.59M as of Q2 2026.
Palacios Wealth Management sold 244 AbbVie shares in Q2 2026, an estimated $52.5K.
AbbVie made up 0.94% of Palacios Wealth Management's portfolio in Q2 2026, its #23 holding.
Palacios Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Palacios Wealth Management's AbbVie position peaked at $1.86M in Q1 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Palacios Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.